Searched for
AURIGENE ONCOLOGY
These large- mid- and small-cap stocks can give more than 25% return in 1 year, according to analysts- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%
- Most difficult: Staying invested in businesses while ignoring noise called Gulf war; 19 stocks from different sectors to ‘hold’
- Will the currency cycle help them? Yes, but very selectively: 10 pharma stocks with upside potential of up to 33%The biggest mistake made in currency cycles is to confuse revenue gain with pure earnings gain. A company may report stronger rupee revenue...28 Mar, 2026, 12.24 PM IST
- China’s India headache: The growing pharmaceutical industryIndian CDMOs are strategically expanding through acquisitions in the US and Europe, driven by global pharma's nearshoring trend and a desir...25 May, 2025, 12.39 PM IST
- Trump & Tariffs: Pharma sector might escape the inevitable tariff troubles. 6 pharma stocks, 5 with an upside potential of up to 38%Exactly eight years ago, in 2016, when a reality TV star became US president, the global markets went into sharp decline on the day of surp...07 Nov, 2024, 11.48 AM IST
- In volatile times, defensive stocks or defensive businesses? The two are different. 7 stocks from second category with an upside potential of up to 32%Last Friday was probably the sixth time in 2024 that practically all sectoral indices were in the red. Needless to say, the market breadth ...27 Oct, 2024, 02.10 PM IST
- Stocks in news: Adani Green, Infosys, Torrent Power, Dr Reddy's, JSW InfraThe IT services company expanded its four year collaboration with Old National Bank to accelerate the Bank’s operational and technological ...09 Oct, 2024, 06.50 AM IST
- Aurigene reports promising phase-1 data for its CAR-T therapy against myelomaAurigene Oncology has announced promising phase-1 results for its novel CAR-T cell therapy, Ribrecabtagene autoleucel, in patients with mul...08 Oct, 2024, 04.56 PM IST
- The yen connection: 4 Indian pharma stocks which benefit from the strength of Japanese yen with an upside potential of up to 15%Every event in the currency market has a twin impact, while some lose but there are others which also gain. But given the mayhem on the str...06 Aug, 2024, 03.51 PM IST
- These healthcare and pharma stocks may deliver more than 20% in one yearCheck out Stock Reports Plus, powered by Refinitiv, for price targets of over 4,000 listed stocks along with detailed company analysis focu...18 Jun, 2024, 12.48 PM IST
- Defensive bet with macro tailwinds? 5 Indian pharma stocks with upside potential of up to 20%On Tuesday, when the whole market was reeling under pressure, two stocks reacted to their numbers in a positive direction. Both of them wer...24 Jan, 2024, 02.46 PM IST
- Getting back into shape? 6 Indian pharma stocks with upside potential of up to 41%The year 2024, started with a correction in nifty, but one set of stocks which were able to outperform were pharma stocks. While it might a...04 Jan, 2024, 02.09 PM IST
- Aurigene inks drug discovery, development pact with US-based EQRxUnder the terms of the collaboration agreement, Aurigene and EQRx will collaborate on drug discovery, pre-clinical and clinical development...04 Jul, 2022, 03.21 PM IST
- Dr Reddy's Laboratories planning mergers and acquisitions to climb up ladderIndia contributed about a fifth or ₹4,196 crore of the company's overall sales of ₹21,439 crore in 2021-22, but domestic business has clock...24 Jun, 2022, 03.54 PM IST
- Dr Reddy's arm inks pact with US-based Olema PharmaceuticalsAurigene will also be eligible for up to USD 60 million in potential clinical development and regulatory milestones and up to USD 370 milli...09 Jun, 2022, 10.27 PM IST
- Like IT sector in the past, everything's coming together for pharma now: GV PrasadIndia is well positioned to be a dominant force in the global generics industry and that is showing.22 Sep, 2020, 03.27 PM IST
- Medical breakthrough! Aurigene closer to developing cancer treatment capsuleThe Bengaluru-based company is an independent subsidiary of Dr Reddy’s Laboratories and its United States-based partner Curis Inc.01 Jul, 2016, 06.50 AM IST
- DRL's Aurigene ties up with US firm CurisCuris has agreed to make payments of up to $52.5 million per programme including $42.5 million for approval and commercial milestones,22 Jan, 2015, 08.49 PM IST
- India's drug discovery and development: Small research firms aim to change face of cancer therapyIndia is not known for developing drugs, let along cancer drugs, but a few small and niche firms are trying exactly that, reports ET.08 May, 2014, 04.55 AM IST
Load More
